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Summary
Anchorage dependence of cell growth is a key metastasis-
suppression mechanism that is mediated by effects of in-
tegrins on growth signaling pathways [1]. The small
GTPase RalA is activated in metastatic cancers through
multiple mechanisms and specifically induces anchorage
independence [2–4]. Loss of integrin-mediated adhesion
triggers caveolin-dependent internalization of cholesterol-
and sphingolipid-rich lipid raft microdomains to the recy-
cling endosomes; these domains serve as platforms for
many signaling pathways, and their clearance from the
plasma membrane (PM) after cell detachment suppresses
growth signaling [5, 6]. Conversely, readhesion triggers
their return to the PM and restores growth signaling.
Activation of Arf6 by integrins mediates exit of raft markers
from the recycling endosomes but is not sufficient for
return to the PM. We now show that RalA but not RalB
mediates integrin-dependent membrane raft exocytosis
through the exocyst complex. Constitutively active RalA
restores membrane raft targeting to promote anchorage-
independent growth signaling. Ras-transformed pancreatic
cancer cells also show RalA-dependent constitutive PM raft
targeting. These results identify RalA as a key determinant
of integrin-dependent membrane raft trafficking and regula-
tion of growth signaling. They therefore define a mechanism
by which RalA regulates anchorage dependence and
provide a new link between integrin signaling and cancer.Results and Discussion
Effect of Ral Inhibition on Cell Spreading and Lipid Raft
Trafficking
When suspended cells are replated on surfaces coated with
fibronectin (FN), return of rafts to the plasma membrane (PM)
is required for cell spreading [6, 7]. To test the role of RalA in
this process, we expressed the Ral-binding domains (RBDs)
of two Ral effectors (Sec5 and RLIP76) that sequester active
Ral and inhibit its function [8–11]. We examined wild-type
(WT) murine embryonic fibroblasts (MEFs) and, as a control,
caveolin12/2 (Cav12/2) MEFs. Because raft microdomains
are not internalized after detachment in Cav12/2 MEFs [6],
these cells do not require the exocytosis pathway [5]. Cells*Correspondence: nb5z@virginia.eduexpressing these constructs (R95% efficiency; see
Figure S1B available online) were detached, held in suspen-
sion for 90 min, and replated on FN. Both Sec5 and RLIP76
RBDs inhibited spreading of WT cells and the return of GPI-
linked proteins (commonly used as raft markers) detected by
binding of proaerolysin [7]. By contrast, Cav12/2 cells were
completely resistant (Figures 1A–1C). Spreading and exocy-
tosis were, however, delayed rather than completely blocked
(data not shown). The RBDs had no effect on raft endocytosis
after detachment (Figure 1B; Figure S1A). These data suggest
a role for Ral proteins in integrin-regulated raft exocytosis and
cell spreading.Knockdown of RalA and RalB
Next, cells were transfected with specific small interfering
RNAs (siRNAs) for RalA and RalB. Loss of RalA (R90%), but
not RalB (R90%), significantly delayed cell spreading and
return of GPI-linked proteins to the cell membrane in readher-
ent WT MEFs (Figure 2A); Cav12/2 MEFs were again
unaffected (Figure 2B). Loss of RalA delayed rather than
completely blocked cell spreading (Figure S2A), as previously
observed for Arf6 inhibitors [7]. Reconstitution of Cav12/2
MEFs with WT Cav1, but not Y14F Cav1, restored membrane
raft endocytosis [5] and sensitivity to RalA siRNA (Figures
S2B and S2C). Earlier studies reported interdependence
between RalA and RalB such that loss of both restored
function compared to loss of single isoforms [12, 13]. However,
loss of RalA plus RalB inhibited cell spreading and membrane
raft localization similarly to loss of RalA alone (Figure 2A).
Neither knockdown affected membrane raft endocytosis after
cell detachment (Figure S2D). Re-expression of siRNA-resis-
tant hRalA*, but not hRalB (Figure S2E), restored spreading
of RalA knockdown cells (Figure 2C). Thus, RalA, but not
RalB, is required for adhesion-dependent raft membrane
targeting and cell spreading.
Activation of RalA and RalB
Next, we measured the effect of cell adhesion to FN on
Ral activation via pull-down assays. RalA activity decreased
by about 40% after detachment and recovered completely
on readhesion (Figure 3A), whereas RalB activity was
unaffected (Figure S3A). Thus, rapid and specific adhesion-
dependent activation of RalA correlates with its stimulation
of raft exocytosis.
Active RalA Promotes Raft Exocytosis in Nonadherent Cells
We next examined the effects of constitutively active RalA on
localization of lipid raft components in nonadherent cells.
Activated fast-cycling RalA 79L expressed at R95% trans-
fection efficiency (Figure S3B) somewhat increased surface
GM1 levels immediately after detachment (z2.6-fold at
0 min in suspension) (Figure 3B) or when adherent (data not
shown). Strikingly, after 90 min in suspension, controls cells
showed nearly complete loss of surface raft components,
whereas RalA 79L-expressing cells showed only an z2-fold
decrease, retaining z10-fold higher levels than control cells
(Figure 3B). Total GM1 and GPI-linked protein levels were
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Figure 1. Ral Inhibition Delays Cell Spreading
and Raft Exocytosis
(A) Wild-type (WT) and Cav12/2 murine embry-
onic fibroblasts (MEFs) expressing Myc-tagged
Ral-binding domains (RBDs) from Sec5 or
RLIP76 were serum starved overnight, sus-
pended for 90 min, and replated on fibronectin
(FN) (2 mg/ml) for 30 min. Cells were fixed and
stained with phalloidin-Alexa 488, and images
were taken. Graph represents spread surface
area/100; values are mean 6 standard error (SE)
in mm2 (n = 95 WT MEFs, n = 70 Cav12/2 MEFs).
Three experiments gave similar results.
(B and C) Suspended and readherent WT (B) and
Cav12/2 (C) MEFs were incubated on ice with
purified proaerolysin for 30 min and then rinsed.
Bound proaerolysin was detected in cell lysate
by western blotting (WB: Aero) with tubulin as
loading control (WB: Tub). RBD constructs were
detected by western blotting for myc (WB:
Myc). Values listed under the aerolysin blot repre-
sent band intensity normalized to tubulin relative
to suspended control cells in each cell type. Blots
are representative of three independent experi-
ments. ****p < 0.00001.
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76unaffected by RalA 79L (Figure S3C). Surface rafts in
suspended RalA 79L-expressing cells were actively endocy-
tosed, but a smaller fraction (y38%) of the total labeled
GM1 was perinuclear in nonadherent cells compared to
untransfected cells (y58%) (Figure S3D), supporting
increased exocytosis as the cause for elevated surface raft
levels. GTPase-deficient active RalA V23 also supported
membrane raft exposure in nonadherent cells, whereas
RalB V23 did not (data not shown).
Active RalA-expressing WT MEFs replated on FN showed
enhanced localization of GM1-labeled vesicles to the cell
periphery at early times (Figure S3D) and spread faster
(data not shown) than control cells. In cells prelabeled with
CTxB, RalA 79L strongly colocalized with the raft marker in
distinct intracellular vesicles and lamellipodia during re-
spreading (Figure 3C) (Pearson’s coefficient = 0.89 6 0.015).
Taken together, these data support the idea that activated
RalA triggers exocytosis of raft microdomains.RalA Effector Site Mutants
Active RalA regulates exocyst assembly to drive exocytic
vesicles to the PM [14]. As a first test for involvement of the
exocyst, we compared effects of RalA 79L to its 49E mutant
that does not bind the exocyst and the 49N mutant that binds
exocyst subunits but does not bind other effectors. Whereas
49N increased surface GM1 levels in suspended cells better
than the parent activated RalA 79L, 49E was significantly
less effective (Figure 3D). All constructs were expressed at
comparable levels (Figure S3E). Surface GM1 levels were
unchanged in Cav12/2 MEFs (data not shown). Thus, the
promotion of membrane raft exocytosis by active RalA 79L
correlates with its exocyst interaction.Role of the Exocyst in Membrane Raft Targeting
We then examined Sec5, an exocyst component and RalA
effector that localizes to the PM and is required for exocyst
function [11, 14–16]. Knockdown of Sec5 in WT MEFs
delayed cell spreading on FN (Figure 4A) and decreasedsurface GPI levels (Figure 4B), whereas Cav12/2 MEFs were
unaffected (Figures S4A and S4B). Next, Sec5-depleted cells
were reconstituted with WT Sec5 or the T11A mutant that
does not bind RalA [16, 17]. WT but not T11A Sec5 restored
cell spreading and raft exocytosis after replating of
knockdown cells (Figures 4C and 4D). Sec5 knockdown
also disrupted PM targeting of raft microdomains in
suspended active RalA 79L-expressing cells (Figure S4C).
During replating, Sec5-GFP colocalized with surface rafts
(GM1) at PM ruffles (Figure 4E), unlike a GFP control (Fig-
ure S4D). Together, these results strongly implicate the
RalA-exocyst complex in adhesion-dependent membrane
targeting of raft microdomains.Active RalA Induces Anchorage-Independent Signaling
Integrin-mediated membrane targeting of raft microdomains
regulates anchorage-dependent PI3-kinase/Akt and Ras/Erk
signaling [5, 6]. Thus, active RalA should increase the activity
of these pathways in suspended cells. In cells treated with
serum for 30 min, expression of active RalA 79L had no effect
on Erk or Akt in adherent cells but substantially increased Akt
(z3.8-fold) and Erk (z2.8-fold) activation in suspended cells
relative to controls (Figures 4F and 4G). Thus, surface rafts
correlate with Erk and Akt activation.
K-Ras activates RalA, which promotes anchorage-indepen-
dent growth in pancreatic and other cancers [4], including
human pancreatic MiaPaCa2 cells [3]. Knockdown of
RalA but not RalB in these cells reduced surface GPI-linked
protein levels in suspended cells (Figures 4H and 4I). These
knockdowns did not affect Cav1, pY14Cav1, or Arf6 levels
(Figure 4H), nor did they affect GM1 endocytosis
(Figure S4E). These results support the role of RalA in control-
ling membrane raft exocytosis and PM localization to promote
anchorage independence in human cancer cells.Conclusions
Previous studies showed that upon detachment of
anchorage-dependent cells from the substratum, membrane
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Figure 2. Effects of Ral Knockdown on Cell
Spreading and Surface Rafts
(A and B) WT MEFs (A) and Cav12/2 MEFs (B)
were transfected with RalA small interfering
RNA (siRNA) (RalA KD), RalB siRNA (RalB KD),
both (RalA + RalB KD), or control siRNA (CON).
Cells were detached, held in suspension for 90
min, and replated on FN (2 mg/ml) for 20 min. Cells
were fixed and stained with phalloidin-Alexa 488,
and images were taken. Graph represents spread
surface area/100; values are mean 6 SE in mm2
(>100 cells were analyzed per experiment; three
independent experiments gave similar results).
Surface binding of proaerolysin was measured
as in Figure 1 (WB: Aero) with tubulin (WB: Tub)
as loading control (right). Values represent band
intensity normalized to tubulin relative to control
90 min suspended cell band intensity. RalA and
RalB expression were detected by western
blotting (WB: RalA, RalB).
(C) RalA-depleted WT MEFs were transfected
with vectors for HA-tagged siRNA-resistant
human RalA (hRalA*) or human RalB. Cells were
treated as above, and spreading was quanti-
tated. Graph represents spread surface area/
100; values are mean 6 SE in mm2 (n = 128 cells).
Two independent experiments gave similar
results. Quantified values represent endogenous
RalA (indicated by)) band intensity normalized
to tubulin. Mutant siRNA-resistant hRalA and
RalB are indicated by d. ****p < 0.00001 to
**p < 0.001.
RalA Mediates Integrin-Dependent Raft Exocytosis
77rafts are endocytosed through caveolae and transported to
the recycling endosome [7]. Upon replating, membrane rafts
are exocytosed by a caveolin-independent, Arf6- and micro-
tubule-dependent pathway that promotes cell spreading.
Adhesion-dependent activation of Arf6, though necessary,
is not sufficient to deliver raft microdomains to the PM.
Thus, there must be an additional adhesion-dependent step.
We now show that adhesion-dependent activation of RalA
is also required for raft exocytosis. Inhibiting RalA function
(Sec5 RBD, RLIP76 RBD, siRNA) significantly delayed cell
spreading and PM delivery of raft components in WT
MEFs. Expression of active RalA promoted PM raft localiza-
tion in nonadherent cells. RalB neither was activated by
adhesion nor affected spreading or raft exocytosis. Thus,the pathway is specifically regulated
by RalA. Differential activation of RalA
and RalB during cytokinesis by iso-
form-specific RalGEFs has also been
described [18]. Integrins may similarly
activate a RalA-specific guanine nucle-
otide exchange factor.
The exocyst subunit Sec5 is required
for cell spreading and raft exocytosis
after replating or after RalA activation
in suspended cells. Sec5 binding to
RalA is required, because Ral-binding-
deficient Sec5 T11A did not restore cell
spreading after Sec5 knockdown. RalA
was reported to bind Sec5 better than
RalB and to localize to the midbody
during cytokinesis [18]. We also
observed localization of Sec5 with RalA
and raft markers at the PM during cellspreading. These findings strongly suggest that RalA mediates
adhesion-dependent exocytic raft trafficking through the
exocyst.
Active RalA-mediated PM localization of raft microdomains
in suspended cells promotes anchorage-independent growth
signaling (Erk, Akt activation). RalA can be activated in
cancer by overexpression, oncogenic Ras, Aurora kinase,
loss of tumor suppressors (e.g., merlin), or viral oncogenes
[2–4, 10, 11]. These data therefore reveal a mechanism by
which activated RalA can promote anchorage independence.
Further work will be required to determine how integrin-
mediated adhesion activates RalA, to characterize the
molecular determinants of the exocytosis pathway, and to
further understand the role of this pathway in human cancer.
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Figure 3. Adhesion-Dependent RalA Activation
Promotes Raft Plasma Membrane Localization
(A) WT MEFs stably adherent (SA), suspended for
90 min (SUS), or replated on FN (10 mg/ml) for 30
min (FN 30’) were assayed for active RalA with
GST-Sec5 RBD beads and western blotting for
RalA (WB: RalA). Graph: active RalA bands were
quantified and normalized to whole-cell lysate
(WCL). Values are means 6 SE, n = 5
(**p < 0.01, *p < 0.05).
(B) Untransfected (CON) and HA-RalA 79L-trans-
fected WT MEFs were serum starved overnight,
detached, held in suspension for 0 min or 90
min, and surface labeled with CTxB-Alexa 594
(GM1-CTxB). Cells were then fixed, and images
were taken. Graph: values are mean surface
intensity 6 SE, n = 10, representative of two
independent experiments. *p < 0.01. Scale bar
represents 5 mm.
(C) HA-tagged RalA 79L-expressing WT MEFs
surface labeled with CTxB-Alexa594 were
suspended and replated on FN (2 mg/ml) for 30
min. Cells were fixed and stained for HA. Arrows
indicate overlap in vesicles and membrane
ruffles. Scale bar represents 20 mm.
(D) Untransfected (CON) MEFs and MEFs
expressing HA-RalA 79L, RalA 79L 49E, or RalA
79L 49N were serum starved overnight,
detached, and held in suspension for 90 min.
Cells were then surface labeled with CTxB-Alexa
594 (GM1-CTxB) and fixed, and images were
taken. Graph: values are mean surface intensity
6 SE, n = 14, representative of two independent
experiments. ****p < 0.00001 to *p < 0.01. Scale
bar represents 10 mm.
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Figure 4. Sec5 and RalA Regulate Membrane
Raft Targeting and Signaling
(A) WT MEFs transfected with control siRNA,
Sec5 siRNA oligo #1 (Sec5-1), or Sec5 siRNA
oligo #2 (Sec5-2) were suspended for 90 min
and replated on FN (2 mg/ml) for 20 min. Cells
were fixed and stained with phalloidin-Alexa
488. Graph represents spread surface area/100;
values are mean6 SE in mm2 (n = 75 cells), repre-
sentative of three independent experiments.
(B) Readherent control and Sec5 siRNA oligo #2-
treated cells (Sec5-2) were incubated on ice with
purified proaerolysin for 30 min. Bound proaero-
lysin was detected in cell lysates by western blot-
ting (WB: Aero). Sec5, RalA, and RalB expression
were confirmed by western blotting (WB). Values
represent band intensity normalized to RalB
levels relative to control.
(C) WT MEFs expressing Sec5 siRNA oligo #2
(Sec5 KD) were transfected with Myc-WT Sec5
(WT Sec5) or Myc-T11A Sec5 (T11A Sec5). Cells
were suspended for 90 min, replated on FN
(2 mg/ml) for 20 min, fixed, and stained with phal-
loidin-Alexa 488. Graph represents spread
surface area/100; values are mean 6 SE in mm2
(n = 65 cells), representative of three independent
experiments.
(D) Readherent cells were incubated on ice with
purified proaerolysin for 30 min. Bound proaero-
lysin was detected in cell lysate by western
blotting (WB: Aero) with tubulin (WB: Tub.) as
a loading control. Graph: aerolysin normalized
to tubulin; values are mean6 SE from three inde-
pendent experiments.
(A–D) ****p < 0.00001; ***p < 0.0001.
(E) WT Sec5-GFP (Sec5-GFP)-expressing WT
MEFs were suspended for 90 min and replated
on FN (2 mg/ml) for 20 min. Cells were chilled,
stained with CTxB-Alexa 594 (Surface GM1),
and fixed.
(F and G) WT MEFs untransfected (CON) or trans-
fected with HA-RalA 79L (RalA 79L) were kept
suspended or adherent for 8 hr without serum
and were then treated with 10% serum for
30 min. Cells were lysed and western blotted for
active (pSer473 Akt) and total Akt (Akt) (F) and
for active (phospho-p44/p42) and total Erk (Erk)
(G). Phosphorylated Akt and Erk were normalized
to total protein. Graph: values are means 6 SE,
n = 4 (pAkt) and n = 3 (pErk).
(H) MiaPaCa2 cells (CON) in which RalA (RalAi) and RalB (RalBi) were stably depleted were analyzed by western blotting (WB) for the indicated proteins.
(I) Control (CON), RalA (RalAi), and RalB (RalBi) knockdown MiaPaCa2 cells were maintained adherent or suspended for 4 hr with serum. Cells were chilled,
and proaerolysin surface labeling was measured as in Figure 1. Bands were quantified and normalized to tubulin. Graph shows proaerolysin binding in sus-
pended cells relative to adherent cells for each condition. Values are means 6 SE, n = 3.
(F–I) **p < 0.01; *p < 0.05.
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